⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for ovarian cancer, epithelial

Every month we try and update this database with for ovarian cancer, epithelial cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Study of NX-1607 in Adults With Advanced MalignanciesNCT05107674
Ovarian Cancer,...
Gastric Cancer
GastroEsophagea...
Head and Neck S...
Metastatic or U...
Non-small Cell ...
Metastatic Cast...
Malignant Pleur...
Triple Negative...
Metastatic Urot...
Cervical Cancer
Diffuse Large B...
Richter Transfo...
Microsatellite ...
NX-1607
Paclitaxel
18 Years - Nurix Therapeutics, Inc.
Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid TumorsNCT05585034
Head and Neck S...
Melanoma Exclud...
Non-small Cell ...
Urothelial Carc...
Renal Cell Carc...
Castration-resi...
Ovarian Cancer,...
TNBC - Triple-N...
Colorectal Canc...
XmAb®808
Keytruda® (pemb...
18 Years - Xencor, Inc.
A Randomized Prospective Trail of HIPEC in Recurrent Ovarian Cancer Patients With HRR MutationNCT04473339
Ovarian Cancer
Epithelial Ovar...
Ovarian Cancer,...
Hyperthermic In...
Homologous Reco...
CRS+HIPEC
CRS alone
18 Years - 75 YearsZhongnan Hospital
Prospective Randomized Trial of Streamlined Genetic Education and Testing for Ovarian Cancer PatientsNCT04537702
Ovarian Cancer,...
Peritoneal Canc...
Fallopian Tube ...
Streamlined Edu...
Traditional Edu...
18 Years - Duke University
A Randomized Prospective Trail of HIPEC in Recurrent Ovarian Cancer Patients With HRR MutationNCT04473339
Ovarian Cancer
Epithelial Ovar...
Ovarian Cancer,...
Hyperthermic In...
Homologous Reco...
CRS+HIPEC
CRS alone
18 Years - 75 YearsZhongnan Hospital
Cytoreductive Surgery(CRS) Plus Hyperthermic Intraperitoneal Chemotherapy(HIPEC) With Lobaplatin in Advanced and Recurrent Epithelial Ovarian CancerNCT03371693
Ovarian Cancer
Ovary Neoplasm
Ovarian Neoplas...
Epithelial Ovar...
Ovarian Cancer,...
Hyperthermic In...
HIPEC
CRS
IVCT
18 Years - 75 YearsZhongnan Hospital
Envafolimab, Lenvatinib Combined With VP-16 in Platinum-resistant Recurrent Epithelial Ovarian CancerNCT05422183
Ovarian Cancer,...
Envafolimab
Lenvatinib
VP-16
18 Years - Zhongda Hospital
A Randomized Prospective Trail of HIPEC in Recurrent Ovarian Cancer Patients With HRR MutationNCT04473339
Ovarian Cancer
Epithelial Ovar...
Ovarian Cancer,...
Hyperthermic In...
Homologous Reco...
CRS+HIPEC
CRS alone
18 Years - 75 YearsZhongnan Hospital
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: